Evidence map›Paper›PMID 39253273›Full record

ArticleHeliyon2024

Newest therapeutic strategies impacting on rarest thoracic malignancies: The clinical case report of biphasic pleural mesothelioma.

F Pellicioli, L Sala, F Colonese, E Belloni, M I Abbate, S Canova, A D'Agostino, D L Cortinovis

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

F PellicioliCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
L SalaCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
F ColoneseCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
E BelloniCS Pathological Anatomy, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
M I AbbateCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
S CanovaCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
A D'AgostinoCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.
D L CortinovisCS Medical Oncology, IRCCS San Gerardo Dei Tintori Foundation, Monza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A caucasian 62-year-old woman, diagnosed with biphasic pleural mesothelioma (PM) of II stage and BAP1 loss, was treated with therapies included in clinical trial and Early Access Programmes (EAP). During her clinical history, radiological images presented an unusual representation of the disease, with a pseudo progression discussed many times by several specialists. The patient's overall survival improved as a result of the multidisciplinary team and the availability of medicines outside of clinical practice.

Indexed as

Case reportClinical trialPleural mesothelioma

Identifiers

PMID39253273
PMCPMC11382305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.